I disagree. It is an opportunity for alzheimer's patients that cannot be missed; FDA approval is conditional and can be revoked if further studies reveal lacki

I disagree. It is an opportunity for alzheimer's patients that cannot be missed; FDA approval is conditional and can be revoked if further studies reveal lacking evidence.